Posted inPress Releases
Cell Therapy Technologies Advance as Curocell and Biruni Group Accelerate CAR-T Therapy Commercialization in Türkiye
South Korean biotechnology company Curocell has strengthened its global expansion strategy by deepening its collaboration with Türkiye's Biruni Group to commercialize its next-generation CAR-T therapy, Rimqarto (anbal-cabtagene autoleucel). The latest…









